This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Apr;141(4):483-6.

doi: 10.4103/0971-5916.159309.

Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents

Varsha Gupta¹, Nidhi Singla, Preeti Behl, Tripti Sahoo, Jagdish Chander

Affiliations

PMID: 26112853
PMCID: PMC4510732
DOI: 10.4103/0971-5916.159309

Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents

Varsha Gupta et al. Indian J Med Res. 2015 Apr.

. 2015 Apr;141(4):483-6.

doi: 10.4103/0971-5916.159309.

Authors

Varsha Gupta¹, Nidhi Singla, Preeti Behl, Tripti Sahoo, Jagdish Chander

Affiliation

¹ Department of Microbiology, Government Medical College Hospital, Sector 32, Chandigarh 160 030, India.

PMID: 26112853
PMCID: PMC4510732
DOI: 10.4103/0971-5916.159309

No abstract available

PubMed Disclaimer

Similar articles

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature.
Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, Hammerum AM, Schaffer K, Burns K, Murchan S, Novais C, Freitas AR, Peixe L, Del Grosso M, Pantosti A, Werner G. Bender JK, et al. Drug Resist Updat. 2018 Sep;40:25-39. doi: 10.1016/j.drup.2018.10.002. Epub 2018 Nov 2. Drug Resist Updat. 2018. PMID: 30447411 Review.
In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Jevitt LA, Smith AJ, Williams PP, Raney PM, McGowan JE Jr, Tenover FC. Jevitt LA, et al. Microb Drug Resist. 2003 Winter;9(4):389-93. doi: 10.1089/107662903322762833. Microb Drug Resist. 2003. PMID: 15000746
Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience.
McKinnell JA, Arias CA. McKinnell JA, et al. Clin Infect Dis. 2015 Sep 15;61(6):879-82. doi: 10.1093/cid/civ449. Epub 2015 Jun 10. Clin Infect Dis. 2015. PMID: 26063714 Free PMC article. No abstract available.
Clinical experience with recently approved antibiotics.
Paterson DL. Paterson DL. Curr Opin Pharmacol. 2006 Oct;6(5):486-90. doi: 10.1016/j.coph.2006.07.001. Epub 2006 Aug 9. Curr Opin Pharmacol. 2006. PMID: 16904377 Review.
Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ. Dowzicky MJ. Clin Ther. 2011 Dec;33(12):1964-73. doi: 10.1016/j.clinthera.2011.10.010. Epub 2011 Nov 10. Clin Ther. 2011. PMID: 22078154

See all similar articles

Cited by

New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354.
Escobar IE, White A, Kim W, Mylonakis E. Escobar IE, et al. Antibiotics (Basel). 2020 Oct 1;9(10):665. doi: 10.3390/antibiotics9100665. Antibiotics (Basel). 2020. PMID: 33019726 Free PMC article.
Biofilm Producing Enterococcus Isolates from Vaginal Microbiota.
Sengupta M, Sarkar S, SenGupta M, Ghosh S, Sarkar R, Banerjee P. Sengupta M, et al. Antibiotics (Basel). 2021 Sep 7;10(9):1082. doi: 10.3390/antibiotics10091082. Antibiotics (Basel). 2021. PMID: 34572664 Free PMC article.
Genotypic characterization of vancomycin-resistant Enterococcus causing urinary tract infection in northern India.
Das AK, Dudeja M, Kohli S, Ray P. Das AK, et al. Indian J Med Res. 2022 Mar;155(3&4):423-431. doi: 10.4103/ijmr.IJMR_2554_19. Indian J Med Res. 2022. PMID: 36124515 Free PMC article.
Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit.
Amberpet R, Sistla S, Parija SC, Rameshkumar R. Amberpet R, et al. J Lab Physicians. 2018 Jan-Mar;10(1):89-94. doi: 10.4103/JLP.JLP_32_17. J Lab Physicians. 2018. PMID: 29403213 Free PMC article.
Characterization of Vancomycin Resistant Enterococci and Drug Ligand Interaction between vanA of E. faecalis with the Bio-Compounds from Aegles marmelos.
V J, A S SG, Gunasekaran S, J VP. V J, et al. J Pharmacopuncture. 2023 Sep 30;26(3):247-256. doi: 10.3831/KPI.2023.26.3.247. J Pharmacopuncture. 2023. PMID: 37799618 Free PMC article.

See all "Cited by" articles

References

1. Murray BE, Weinstock GM. Enterococci: new aspects of an old organism. Proc Assoc Am Physicians. 1999;111:328–34. - PubMed
1. Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10:266–78. - PMC - PubMed
1. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev. 1994;7:462–78. - PMC - PubMed
1. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32(Suppl 2):S133–45. - PubMed
1. Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res. 2008;128:111–21. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations